US Patent Issued to Societe Des Produits Nestle on Oct. 7 for "Peanut oral immunotherapy with maintenance dose" (California Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,945, issued on Oct. 7, was assigned to Societe Des Produits Nestle S.A. (Vevey, Switzerland).

"Peanut oral immunotherapy with maintenance dose" was invented by Daniel Adelman (Brisbane, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to improved oral immunotherapy methods for treating peanut allergy. The disclosure provides methods for treating a subject for a peanut allergy by an oral immunotherapy comprising an up-dosing phase and a maintenance phase. In certain embodiments, the methods comprise non-daily administration to the subject of a maintenance phase dose. In certain embodiments, the methods comprise admi...